FDA may be more willing to bring down the hammer on oncology accelerated approval drug sponsors who fail to conduct their confirmatory trials with due diligence. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
